TransAlgae develops and cultivates a variety of enhanced algae possessing high value products for the growing animal health markets. The company’s innovative (patent pending) technology platform harnesses algae as cell factories for the production of customized or off-the-shelf bio-molecules. The platform enables the development of dried algae, engineered to contain enzymes, active molecules, vaccines or other proteins to be orally delivered to target organisms